Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28810
Title: The Woven EndoBridge Device for the Treatment of Intracranial Aneurysms: Initial Clinical Experience within an Australian Population.
Austin Authors: Gajera, Jay;Maingard, Julian;Foo, Michelle ;Ren, Yifan;Lamanna, Anthony ;Nour, Daniel;Hall, Jonathan;Kurda, Dylan;Tan, David;Lalloo, Shivendra;Bañez, Ramon Martin Francisco;Russell, Jeremy H ;Slater, Lee-Anne;Chandra, Ronil Vikesh;Chong, Winston;Jhamb, Ashu;Brooks, Duncan Mark ;Asadi, Hamed 
Affiliation: Radiology
Neurosurgery
School of Medicine, Deakin University, Waurn Ponds, VIC, Australia
Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, VIC, Australia
Department of Medical Imaging, Interventional Neuroradiology Service, The Canberra Hospital, ACT Health, Canberra, NSW, Australia
Department of Neurosurgery, Royal Hobart Hospital, Hobart, TAS, Australia
Department of Radiology, Interventional Neuroradiology Service, St. Vincent's Hospital, Melbourne, VIC, Australia
Department of Radiology, Royal North Shore Hospital, Sydney, NSW, Australia
Issue Date: Mar-2022
Date: 2022-02-08
Publication information: Neurointervention 2022; 17(1): 28-36.
Abstract: Advances in endovascular technology have expanded the treatment options for intracranial aneurysms. Intrasaccular flow diversion is a relatively new technique that aims to disrupt blood inflow at the neck of the aneurysm, hence promoting intrasaccular thrombosis. The Woven EndoBridge device (WEB; MicroVention, Aliso Viejo, CA, USA) is an US Food and Drug Administration approved intrasaccular flow diverter for wide-necked aneurysms. We report the early interim clinical and radiological outcomes of patients with both ruptured and unruptured intracranial aneurysms (IAs) treated using the WEB device in an Australian population. A retrospective analysis was done of patients with ruptured or unruptured IAs who received treatment with WEB across 5 Australian neuroendovascular referral centers between May 2017 and November 2020. Angiographic occlusion was assessed with time-of-flight magnetic resonance angiography. Complications were recorded and clinical outcomes were assessed using the modified Rankin scale at follow-up. In total, 66 aneurysms were treated in 63 patients, with successful deployment of the WEB device in 98.5% (n=65). Eighteen (26.9%) ruptured aneurysms were included. Failure of deployment occurred in a single case. Adjunct coiling and/or stenting was performed in 20.9% (n=14) cases. Sixty-two patients with 65 aneurysms using a WEB device were followed up (mean=9.1 months), and 89.4% of these had complete aneurysm occlusion while 1.5% remained patent. Functional independence was achieved in 93.5% of cases. Early results following the use of WEB devices in Australia demonstrate safety and adequate aneurysm occlusion comparable to international literature.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28810
DOI: 10.5469/neuroint.2021.00430
ORCID: 0000-0001-8958-2411
0000-0001-8056-1163
0000-0001-6518-6828
0000-0003-0705-2252
0000-0001-5034-570X
0000-0003-3692-120X
0000-0003-2475-9727
Journal: Neurointervention
PubMed URL: 35130672
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35130672/
ISSN: 2093-9043
Type: Journal Article
Subjects: Endovascular procedures
Flow diversion
Intracranial aneurysm
Intrasaccular
WEB
Woven EndoBridge device
Appears in Collections:Journal articles

Show full item record

Page view(s)

24
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.